Invesco Defence Innovation UCITS ETF Acc

Investment objective: The objective of the Fund is to provide exposure to the performance of global listed companies that are developing sophisticated weapons, defensive systems and other solutions for securing borders. Investment approach: The Fund is a passively managed ETF. In order to achieve the investment objective, the Fund will seek to replicate the net total return performance of the of the S&P Kensho Global Future Defense Index (the 'Index'), less fees, expenses and transaction costs. The Fund will as far as possible and practicable, replicate the Index by holding all the securities in the Index in a similar proportion to their respective weightings in the Index. The Fund may use derivative instruments for the purposes of managing risk, reducing costs, generating additional capital or income. The Fund may engage in securities lending, whereby 90% of the revenues arising from securities lending will be returned to the Fund and 10% of the revenues will be retained by the securities lending agent. The Fund may be exposed to the risk of the borrower defaulting on its obligation to return the securities at the end of the loan period and of being unable to sell the collateral provided to it if the borrower defaults. The Fund's base currency is USD. The Index: The S&P Kensho Global Future Defense Index (the 'Index') tracks the performance of global listed companies that are developing sophisticated weapons, defensive systems and other solutions for securing borders. The Index is constructed by selecting securities from a broad equity universe which includes only developed market countries as defined by the Index provider. The Index screens securities from the eligible universe to exclude those that do not meet minimum liquidity criteria; further details on the liquidity threshold criteria can be found in the Index methodology. Companies are then assessed and selected if they are determined by the Index provider to be focused on developing sophisticated weaponry &

Physical replication

PIR compliant

No

PEA compliant

No

PEA-PME compliant

No